Apeiron Investment Group Ltd. - Significant Ownership

Signature - Title
/s/ Mario Frendo - Mario Frendo, Director
Location
Sliema, Malta
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Apeiron Investment Group Ltd..

Significant Ownership of Apeiron Investment Group Ltd.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
IGXT ATAI Life Sciences N.V. Ordinary Shares, par value Euro 0.10 per share 24% 56.6M +0.09% Christian Angermayer Oct 16, 2025
NEUP Neuphoria Therapeutics Inc. Common Stock 4.5% $356K 72.6K Apeiron Investment Group Ltd. Jan 24, 2025

Schedules 13D/G Reported by Apeiron Investment Group Ltd.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.